PetMed Express (PETS) Stock Price, News & Analysis

Company Overview

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Key Stats

• Today's Range: $2.95 to $3.13
• 50-Day Range: $2.96 to $4.19
• 52-Week Range: $2.81 to $6.85
• Volume: 99,567 shs
• Average Volume: 194,608 shs
• Market Capitalization: $61.15 million
• P/E Ratio: 296.30
• Dividend Yield: N/A
• Price Target: $3.20
• Consensus Rating: Sell

PetMed Express Stock Analysis - MarketRank™

PetMed Express scored higher than 9% of companies evaluated by MarketBeat, and ranked 207th out of 211 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

PetMed Express has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

PetMed Express has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -84.21%

Earnings Growth

Earnings for PetMed Express are expected to decrease by -84.21% in the coming year, from $0.19 to $0.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PetMed Express is 296.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.67.

Price to Earnings Ratio vs. Sector

The P/E ratio of PetMed Express is 296.30, which means that it is trading at a more expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 26.06.

Price to Book Value per Share Ratio

PetMed Express has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.79% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 12.8, which indicates bearish sentiment.

Change versus previous month

Short interest in PetMed Express has recently increased by 20.39%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PetMed Express does not currently pay a dividend.

Dividend Growth

PetMed Express does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.79% of the float of PetMed Express has been sold short.

Short Interest Ratio / Days to Cover

PetMed Express has a short interest ratio ("days to cover") of 12.8, which indicates bearish sentiment.

Change versus previous month

Short interest in PetMed Express has recently increased by 20.39%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.54

News Sentiment

PetMed Express has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Retail/Wholesale companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for PetMed Express this week, compared to 3 articles on an average week.

Search Interest

7 people have searched for PETS on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added PetMed Express to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, PetMed Express insiders have bought more of their company's stock than they have sold. Specifically, they have bought $894,490.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.10% of the stock of PetMed Express is held by insiders.

Percentage Held by Institutions

73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PETS Stock Analysis - Frequently Asked Questions

How have PETS shares performed this year?

PetMed Express' stock was trading at $4.82 at the start of the year. Since then, PETS shares have decreased by 38.6% and is now trading at $2.96.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings data on Monday, February, 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.02. PetMed Express had a trailing twelve-month return on equity of 0.37% and a net margin of 0.14%.
Read the conference call transcript.

Who are PetMed Express' major shareholders?

PetMed Express' top institutional investors include Arrowstreet Capital Limited Partnership (1.19%), Geode Capital Management LLC (1.06%), Truffle Hound Capital LLC (0.58%) and Bank of America Corp DE (0.37%). Insiders that own company stock include Silvercape Investments Ltd, Nina Capital Holdings Inc, Mathew N Hulett, Sandra Yvette Campos, Gian Fulgoni, Jacqueline Paula Smith and Christine Chambers.
View institutional ownership trends.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL).

Company Calendar

• Last Earnings: 2/10/2025
• Today: 8/16/2025
• Next Earnings (Estimated): 8/19/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Retail/Wholesale
• Industry: INTERNET COMMERCE
• Sub-Industry: Internet Retail
• Current Symbol: NASDAQ:PETS
• CIK: 1040130
• Web: www.1800petmeds.com
• Phone: (561) 526-4444
• Fax: 561-526-4445
• Employees: 210
• Year Founded: 1996

Price Target and Rating

• Average Price Target for PetMed Express: $3.20
• High Price Target: $3.20
• Low Price Target: $3.20
• Potential Upside/Downside: +8.1%
• Consensus Rating: Sell
• Rating Score (0-4): 1.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 296.30
• Forward P/E Ratio: 15.58
• P/E Growth: N/A
• Net Income: -$7.46 million
• Net Margins: 0.14%
• Pretax Margin: 0.78%
• Return on Equity: 0.37%
• Return on Assets: 0.23%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.43
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $281.06 million
• Price / Sales: 0.22
• Cash Flow: $0.02 per share
• Price / Cash Flow: 136.02
• Book Value: $4.57 per share
• Price / Book: 0.65

Miscellaneous

• Outstanding Shares: 20,660,000
• Free Float: 20,429,000
• Market Cap: $61.15 million
• Optionable: Optionable
• Beta: 0.82